Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively used in the labelling of antibodies and nanoparticules. 89Zr can be produced by cyclotron via an 89Y(p,n)89Zr reaction while using an 89Y-foil target. In this study, we investigated for the first time the use of 89Y-pressed target for the preparation of 89Zr-oxalate via a (p,n) reaction. We performed comparative studies with an 89Y-foil target mounted on custom-made target supports. A new automated cassette-based purification module was used to facilitate the purification and the fractionation of 89Zr-oxalate. The effective molar activity (EMA) was calculated for both approaches via titration with deferoxamine (DFO). The radionuclidic purity wa...
none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target...
The use of radionuclides plays a crucial role in Nuclear Medicine in the areas of diagnostics, of me...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively us...
Introduction Zr-89 is a useful radionuclide for radiolabeling proteins and other molecules.1,2 There...
Zirconium 89 ($\text{}^{89}Zr$) is a promising radionuclide for development of new PET agents due to...
Zirconium-89 (Zr-89) is an emerging radionuclide for positron emission tomography (PET), with nuclea...
Few PET isotopes are suitable for antibody labelling since immunoPET requires that the PET isotope c...
Zirconium 89 (89Zr) is a promising radionuclide for development of new PET agents due to its conveni...
Zirconium-89 is a promising radionuclide for nuclear medicine. The aim of the present work was to fi...
Zr-89 was produced in high amounts (130 mCi/h) via a (p,n) reaction on Y-89. The Zr-89-isotope was p...
Zirconium-89 is a promising radionuclide in the development of new immuno-PET agents for in vivo ima...
The radionuclide zirconium-89 can be employed for the positron emission tomography (PET). In this st...
89Zr (T1/2 = 3.27 d) is an important β+-emitting radionuclide of zirconium used in immuno PET. The e...
The 89Zr is one of the most promising radionuclide in Nuclear Medicine for labelling monoclonal anti...
none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target...
The use of radionuclides plays a crucial role in Nuclear Medicine in the areas of diagnostics, of me...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively us...
Introduction Zr-89 is a useful radionuclide for radiolabeling proteins and other molecules.1,2 There...
Zirconium 89 ($\text{}^{89}Zr$) is a promising radionuclide for development of new PET agents due to...
Zirconium-89 (Zr-89) is an emerging radionuclide for positron emission tomography (PET), with nuclea...
Few PET isotopes are suitable for antibody labelling since immunoPET requires that the PET isotope c...
Zirconium 89 (89Zr) is a promising radionuclide for development of new PET agents due to its conveni...
Zirconium-89 is a promising radionuclide for nuclear medicine. The aim of the present work was to fi...
Zr-89 was produced in high amounts (130 mCi/h) via a (p,n) reaction on Y-89. The Zr-89-isotope was p...
Zirconium-89 is a promising radionuclide in the development of new immuno-PET agents for in vivo ima...
The radionuclide zirconium-89 can be employed for the positron emission tomography (PET). In this st...
89Zr (T1/2 = 3.27 d) is an important β+-emitting radionuclide of zirconium used in immuno PET. The e...
The 89Zr is one of the most promising radionuclide in Nuclear Medicine for labelling monoclonal anti...
none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target...
The use of radionuclides plays a crucial role in Nuclear Medicine in the areas of diagnostics, of me...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...